–
–
Virbac raises its annual outlook, driven by a very dynamic market
PARIS (Agefi-Dow Jones) – The veterinary laboratory Virbac on Monday raised its outlook for 2021, underlining the “excellent dynamism” of the animal health sector during the first months of the year.
The group is now anticipating growth in its turnover at constant rates and scope of between 10% and 14%, or between 7% and 11% at constant rates and actual scope. In addition, Virbac now expects a ratio of current operating income before amortization of assets resulting from acquisitions to sales of “around 15%” at constant exchange rates.
In addition, the company forecasts for this year an unfavorable impact of exchange rates on sales of around 13 million euros linked to the depreciation of currencies.
The company previously counted on a growth in its turnover at constant rates and perimeter of between 6% and 10%, that is to say between 3% and 7% at constant rates and actual perimeter, and on a ratio of “current operating income before amortization of assets resulting from acquisitions “on sales of between 12% and 14% at constant exchange rates.
“Many indicators such as visits to veterinarians, the number of pet adoptions as well as the rebound observed in the production animal segment are very positively oriented and should continue to support the growth of the healthcare market. animal in 2021, “the group said in a statement.
“For the months to come, the health crisis could still create uncertainty and impact our activities,” added Virbac, however.
-François Berthon, Agefi-Dow Jones; 01 41 27 47 93; [email protected] ed: LBO
Agefi-Dow Jones The financial newswire
Dow Jones Newswires
July 05, 2021 12:27 ET (16:27 GMT)
–
–
